Article
Yin Yang Interactomes Drive the Metabolic Dysfunction-Associated Liver Disease Continuum to Hepatocellular Carcinoma
2026-01-09
Abstract excerpt
The risk for hepatocellular carcinoma (HCC) arising from metabolic dysfunction– associated steatotic liver disease (MASLD)–related cirrhosis exceeds the risk for cancer developing in the kidney, heart, or lung as a consequence of end-stage disease in those organs. Both experimental and clinical studies support the existence of circulating biomarkers whose elevated expression is associated with, and supports the di...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d3ae4db7-e65f-5f65-800e-dfb99046b553
- DOI
- 10.64898/2026.01.06.698028
